Well-known television physician Dr Dawn Harper spent a decade ignoring routine medical flags indicating she was on the verge of developing type 2 diabetes. Despite maintaining a healthy body mass index of 19, eating home-grown vegetables, and keeping an active lifestyle, the former co-host of Embarrassing Bodies received a formal diagnosis of the condition in July 2023. She was surprised to discover that a single dietary staple was pushing her blood sugar into dangerously high ranges, and eliminating it helped her avoid medication.
The situation mirrors the experiences of an estimated 6.3 million people in the United Kingdom currently living with prediabetes. For years, the 63-year-old medical professional dismissed early warnings because she did not fit the traditional physical profile associated with metabolic disorders. After purchasing and wearing a continuous glucose monitor on the back of her arm, she finally identified the specific driver behind her elevated readings.
How a Continuous Glucose Monitor Revealed the Danger Food
To understand why her blood sugar remained high despite her healthy habits, Dr Harper purchased a Yuwell Anytime continuous glucose monitor. These wearable devices track glucose levels in real time via a tiny sensor on the arm, removing the need for frequent finger-prick tests and logging responses to specific meals through a smartphone application.
Expecting her occasional glass of wine to trigger a warning, she was surprised when the alcohol caused no change in her readings. Instead, standard lunch items such as a ham and cheese sandwich or a chicken Caesar wrap sent her glucose levels past 20 mmol/L, well above the safe threshold of 3.9 to 11.1 mmol/L. Testing confirmed that any variety of bread caused a severe spike, while smaller portions of other carbohydrates like rice or potatoes kept her within safe parameters.
The Journey from Prediabetes Diagnosis to LADA
Dr Harper first encountered warnings about her blood sugar in 2013 while filming a spin-off for Channel 4, where an HbA1c blood test measured her average levels over the previous two to three months. A normal reading sits below 42 mmol/mol, while measurements between 42 and 47.9 mmol/mol indicate prediabetes. Although a researcher advised her to get the result checked, she dismissed it as a lab error due to her fitness and lack of a sweet tooth.
Seven years passed before an NHS Health Check in 2022 revealed an HbA1c reading of 44 mmol/mol, followed by a reading of 48 mmol/mol in 2023 that crossed into type 2 diabetes territory. Her physician initially prescribed metformin, which produced little change in her glucose levels. In 2025, enrollment in a research study at Bristol University provided a correct diagnosis of latent autoimmune diabetes in adults, a slower-developing condition often referred to as type 1.5 diabetes.
Understanding Latent Autoimmune Diabetes in Adults
Often misdiagnosed as type 2 diabetes because it develops later in life, latent autoimmune diabetes in adults shares traits with both type 1 and type 2 conditions. While classic type 1 diabetes typically appears in childhood as an autoimmune reaction where the body stops producing insulin, latent autoimmune diabetes in adults develops gradually and usually affects individuals at a healthy weight.
Medical professionals test for the condition by searching the blood for GADA antibodies, which indicate that the immune system is slowly attacking the pancreas. Although oral medications like metformin are initially prescribed, patients with this form of the disease typically transition to insulin injections much faster than those with standard type 2 diabetes as the pancreas loses function.
The Campaign for Broader Access to Glucose Monitoring Tech
Continuous glucose monitors are currently restricted on the National Health Service to individuals with type 1 diabetes, numbering around 400,000 people, and high-risk patients with type 2 diabetes. Purchasing the technology privately requires sensors costing between £50 and £120 a month, alongside upfront costs for transmitters and application subscriptions. Patient advocacy groups, including Diabetes UK through campaigns like Diabetes Tech Can't Wait, are pushing for wider availability.
Dr Harper believes that expanding access to these devices for everyone diagnosed with prediabetes could prevent the condition from advancing and save millions of pounds in treatment costs. Poorly controlled glucose damages nerves and blood vessels over time, contributing to severe medical complications such as heart disease, strokes, kidney failure, blindness, and amputations. In the UK, diabetes currently accounts for an estimated £10.7 billion in spending, with 60 percent directed toward managing complications.